Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial-Reference-Cited by-同舟云学术

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

Published:2012-02 Issue:2 Volume:13 Page:145-153
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bourhis Jean,Sire Christian,Graff Pierre,Grégoire Vincent,Maingon Philippe,Calais Gilles,Gery Bernard,Martin Laurent,Alfonsi Marc,Desprez Patrick,Pignon Thierry,Bardet Etienne,Rives Michel,Geoffrois Lionel,Daly-Schveitzer Nicolas,Sen Sok,Tuchais Claude,Dupuis Olivier,Guerif Stéphane,Lapeyre Michel,Favrel Véronique,Hamoir Marc,Lusinchi Antoine,Temam Stéphane,Pinna Antonella,Tao Yun Gan,Blanchard Pierre,Aupérin Anne

Publisher

Elsevier BV

Subject

Oncology

Reference26 articles.

1. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data;Pignon;Lancet,2000

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer;Posner;N Engl J Med,2007

4. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer;Vermorken;N Engl J Med,2007

5. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study;Paccagnella;Ann Oncol,2010

Cited by 310 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoscopic submucosal dissection for lesions developing in the irradiated area of head and neck cancer;Journal of Gastroenterology and Hepatology;2024-08-16

2. Clinical Experience With an Offline Adaptive Radiation Therapy Head and Neck Program: Dosimetric Benefits and Opportunities for Patient Selection;International Journal of Radiation Oncology*Biology*Physics;2024-08

3. A single dose of radiation elicits comparable acute salivary gland injury to fractionated radiation;Disease Models & Mechanisms;2024-08-01

4. Organs-at-risk dose and normal tissue complication probability with dynamic trajectory radiotherapy (DTRT) for head and neck cancer;Radiotherapy and Oncology;2024-06

5. Outcomes of postoperative radiotherapy combined with or without chemotherapy for locally advanced oral cancer: A systematic review and meta-analysis;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2024-06